Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Arthritis and Rheumatism|April 9, 2005
Homeostatic effects of the metalloproteinase disintegrin ADAM15 in degenerative cartilage remodelingBeate B Böhm, Thomas Aigner, Barbara Roy, et al.
Arthritis and Rheumatism|March 7, 2012
Class II major histocompatibility complex-associated response to type XI collagen regulates the development of chronic arthritis in ratsJonatan Tuncel, Sabrina Haag, Stefan Carlsén, et al.
Science Advances|May 19, 2018
Mannan-induced Nos2 in macrophages enhances IL-17-driven psoriatic arthritis by innate lymphocytesJianghong Zhong, Tatjana Scholz, Anthony C Y Yau, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2002
Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritisJohan Bäcklund, Stefan Carlsen, Torsten Höger, et al.
Arthritis and Rheumatism|January 1, 2008
Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammationKutty Selva Nandakumar, Estelle Bajtner, Leigh Hill, et al.
Arthritis and Rheumatism|July 13, 2004
Antileukoproteinase: modulation of neutrophil function and therapeutic effects on anti-type II collagen antibody-induced arthritisBettina Sehnert, Andrea Cavcic, Beate Böhm, et al.
Scientific Reports|March 22, 2025
Mechanical forces trigger invasive behavior in synovial fibroblasts through N-cadherin/ADAM15 -dependent modulation of LncRNA H19Tomasz Janczi, Beate Böhm, Yuliya Fehrl, et al.
BMC Rheumatology|December 24, 2019
Use of a "critical difference" statistical criterion improves the predictive utility of the Health Assessment Questionnaire-Disability Index score in patients with rheumatoid arthritisFrank Behrens, Michaela Koehm, Eva C Schwaneck, et al.
Medicine|May 9, 2020
Does concomitant methotrexate confer clinical benefits in patients treated with prior biologic therapy? Analysis of data from a noninterventional study of rheumatoid arthritis patients initiating treatment with adalimumabMarc Schmalzing, Frank Behrens, Eva C Schwaneck, et al.
Rheumatology (Oxford, England)|July 17, 2018
Minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumabFrank Behrens, Michaela Koehm, Eva C Schwaneck, et al.
Pageof 10